脊髓髓内海绵状血管瘤的手术策略与长期结局:219例单中心连续病例分析
该单中心回顾性研究纳入2002至2017年219例手术治疗的脊髓髓内海绵状血管瘤患者,评估手术策略与预后预测因素。结果显示全切除率达98.1%,长期随访有利结局占86.1%,术前轻度神经功能状态和胸腰段病变是术后早期恶化的独立预测因素。
要点
- 全切除率达98.1%,长期有利结局占86.1%。
- 术前轻度功能状态和胸腰段病变预测术后早期恶化。
- 病变深度与长期不良结局相关,直接切开黄色异常表面预测恶化。
核心结论
- 个体化手术入路切除仍是脊髓髓内海绵状血管瘤的主要治疗选择。
- 对轻度症状的胸腰段病变及深部嵌入病变手术需更谨慎。
研究设计与样本
- 单中心回顾性研究,纳入2002至2017年连续219例手术治疗患者。
- 采用ASIA损伤量表评估神经功能,分析患者特征、手术入路及术后近远期结局。
主要发现
- 平均病变大小10.5 mm;颈段24.8%、胸段73.4%、腰段1.8%。
- 水平位置:腹侧30.4%、背侧41.6%、中央28.0%。
- 214例手术评估患者中,62.6%病变表浅,37.4%嵌入。
- 全切除率98.1%,术后即刻神经功能恶化率10.3%。
- 187例平均随访45.9个月:稳定63.1%、改善33.2%、恶化3.7%,有利结局86.1%。
关键数值与推荐
- 多因素logistic回归:术前轻度功能(p=0.014,OR 4.5,95%CI 1.4-14.8)和胸腰段病变(p=0.01,OR 15.7,95%CI 1.9-130.2)为术后恶化的独立预测因素。
- 长期有利结局与术前轻度神经功能和残疾状态(p=0.000)及颈段病变(p=0.009)显著相关。
- 病变深度与长期不良结局相关(p=0.001)。
- 中度深度病变直接切开黄色异常表面为恶化的独立预测因素(p=0.023,OR 35.3,95%CI 1.6-756.3)。
临床怎么用
- 根据病变水平位置和深度选择个体化手术入路。
- 对胸腰段病变及深部嵌入病变,即使症状轻微也应审慎评估手术指征。
- 术中避免直接切开黄色异常表面,尤其对于中度深度病变。
局限性
- 单中心回顾性设计可能存在选择偏倚。
- 部分患者失访,长期随访仅纳入187例。
- 手术策略随时间演变可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Optimal surgical strategies for intramedullary spinal cord cavernous malformations (ISCCMs) are not optimized and remain problematic. In this study the authors identify rational surgical strategies for ISCCMs and predictors of outcomes after resection. METHODS: A single-center study was performed with 219 consecutive surgically treated patients who presented from 2002 to 2017 and were analyzed retrospectively. The American Spinal Injury Association (ASIA) Impairment Scale was used to evaluate neurological functions. Patient characteristics, surgical approaches, and immediate and long-term postoperative outcomes were identified. RESULTS: The average ISCCM size was 10.5 mm. The spinal level affected was cervical in 24.8% of patients, thoracic in 73.4%, and lumbar in 1.8%. The locations of the lesions in the horizontal plane were 30.4% ventral, 41.6% dorsal, and 28.0% central. Of the 214 patients included in the cohort for operative evaluation, 62.6% had superficially located lesions, while 37.4% were embedded. Gross-total resection was achieved in 98.1% of patients. The immediate postoperative neurological condition worsened in 10.3% of the patients. Multivariate logistic regression identified mild preoperative function (p = 0.014, odds ratio [OR] 4.5, 95% confidence interval [CI] 1.4-14.8) and thoracolumbar-level lesions (p = 0.01, OR 15.7, 95% CI 1.9-130.2) as independent predictors of worsening. The mean follow-up duration in 187 patients was 45.9 months. Of these patients, 63.1% were stable, 33.2% improved, and 3.7% worsened. Favorable outcomes were observed in 86.1% of patients during long-term follow-up and were significantly associated with preoperative mild neurological and disability status (p = 0.000) and cervically located lesions (p = 0.009). The depths of the lesions were associated with worse long-term outcomes (p = 0.001), and performing myelotomy directly through a yellowish abnormal surface in moderate-depth lesions was an independent predictor of worsening (p = 0.023, OR 35.3, 95% CI 1.6-756.3). CONCLUSIONS: Resection performed with an individualized surgical approach remains the primary therapeutic option in ISCCMs. Performing surgery in patients with mild symptoms at the thoracolumbar level and embedded located lesions requires more discretion.
引用
- Ren J, Hong T, He C, et al. Surgical approaches and long-term outcomes of intramedullary spinal cord cavernous malformations: a single-center consecutive series of 219 patients. J Neurosurg Spine. 2019. PMID: 30952112. doi:10.3171/2018.12.SPINE181263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。